Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Pre-Tax Margin Over TimeContracting
Percentile Rank93
3Y CAGR+10.4%
Studio
Year-over-Year Change

Pre-tax income as a percentage of revenue

3Y CAGR
+10.4%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM12.38%-43.6%
202421.95%+132.4%
2023-67.84%-837.3%
20229.20%+100.8%
2021-1198.32%-346.3%
2020-268.48%-
20190.00%+100.0%
2018-500916.67%-23550.7%
2017-2117.98%+50.1%
2016-4246.87%-